VS-7375

· Verastem, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VS-7375, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors [Phase 1, Phase 2]